No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SDGR241220P17500
- 0.12
- +0.07+140.00%
15min DelayClose Dec 20 15:59 ET
0.12High0.12Low
0.12Open0.05Pre Close1 Volume156 Open Interest17.50Strike Price12.00Turnover8803.45%IV10.60%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type-0.1250Delta0.1111Gamma162.00Leverage Ratio-442.6727Theta0.0000Rho-20.26Eff Leverage0.0000Vega
Intraday
- 5D
- Daily
News
AI Driven Drug Discovery Patent Landscape Report 2024: 1,087 Patents Analyzed With Market Sales Data and Growth Rates - ResearchAndMarkets.com
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
Express News | Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Schrodinger Inc: Received an Additional $9.5 Mln From Bill & Melinda Gates Foundation